Clinical Trial Update: Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating nab-paclitaxel with cisplatin vs nab-paclitaxel alone as induction therapy for locally advanced squamous cell carcinoma of the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• CISPLATIN (cisplatin)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Squamous Cell Carcinoma of the Head and Neck, Carcinoma, Squamous Cell of the Head and Neck | Phase 2 | Status: COMPLETED | Results posted: 2021-03-02